(Q46890015)

English

Population pharmacokinetics and pharmacodynamics of doxorubicin and cyclophosphamide in breast cancer patients: a study by the EORTC-PAMM-NDDG.

scientific article published in January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Population pharmacokinetics and pharmacodynamics of doxorubicin and cyclophosphamide in breast cancer patients: a study by the EORTC-PAMM-NDDG. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

21

object named as

Jos H Beijnen

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

20

object named as

Chris Twelves

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Alwin D R Huitema

2

object named as

Alwin D R Huitema

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Mats O Karlsson

17

object named as

Mats Karlsson

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Jan H M Schellens

22

object named as

Jan H M Schellens

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

author name string

Markus Joerger

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Dick J Richel

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Christian Dittrich

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Nikolas Pavlidis

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Evangelos Briasoulis

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Jan B Vermorken

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Elena Strocchi

8

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Andrea Martoni

9

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Roberto Sorio

10

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Henk P Sleeboom

11

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Miguel A Izquierdo

12

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Duncan I Jodrell

13

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Régine Féty

14

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Ernst de Bruijn

15

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Georg Hempel

16

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Brigitte Tranchand

18

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Ad H G J Schrijvers

19

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

EORTC-PAMM-NDDG

23

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Clinical Pharmacokinetics

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

46

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

12

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

1051-1068

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

https://scigraph.springernature.com/pub.10.2165/00003088-200746120-00005

0 references

Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Semiphysiological model for the time course of leukocytes after varying schedules of 5-fluorouracil in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of cyclophosphamide (CP) and 4-OH-CP/aldophosphamide in systemic vasculitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of doxorubicin and metabolites in murine specimens by high-performance liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous determination of N,N',N"-triethylenethiophosphoramide, cyclophosphamide and some of their metabolites in plasma using capillary gas chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensification of adjuvant chemotherapy: 5-year results of a randomized trial comparing conventional doxorubicin and cyclophosphamide with high-dose mitoxantrone and cyclophosphamide with filgrastim in operable breast cancer with 10 or more involve

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism-based cyclophosphamide dosing for hematopoietic cell transplant

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with Thiotepa and Carboplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and metabolism of 4'-iodo-4'-deoxy-doxorubicin in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Model of chemotherapy-induced myelosuppression with parameter consistency across drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significant induction of cyclophosphamide and thiotepa metabolism by phenytoin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of age on the early disposition of doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Doxorubicin pharmacokinetics is correlated to the effect of induction therapy in children with acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Model describing the relationship between pharmacokinetics and hematologic toxicity of the epirubicin-docetaxel regimen in breast cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics with survival, toxicity, and dosing weight in patients with primary breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant chemotherapy with doxorubicin and cyclophosphamide in women with rapidly proliferating node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A limited sampling strategy for cyclophosphamide pharmacokinetics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Doxorubicin pharmacokinetics: the effect of abnormal liver biochemistry tests

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second consensus on medical treatment of metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors affecting pharmacokinetic variability following doxorubicin and docetaxel-based therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limited sampling models for doxorubicin pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18027989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003088-200746120-00005

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18027989

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46890015&oldid=2143966140"